433 related articles for article (PubMed ID: 24797715)
1. Information-based sample size re-estimation in group sequential design for longitudinal trials.
Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
[TBL] [Abstract][Full Text] [Related]
2. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
3. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
4. Sample size re-estimation for adaptive sequential design in clinical trials.
Gao P; Ware JH; Mehta C
J Biopharm Stat; 2008; 18(6):1184-96. PubMed ID: 18991116
[TBL] [Abstract][Full Text] [Related]
5. Optimal adaptive group sequential design with flexible timing of sample size determination.
Cui L; Zhang L; Yang B
Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
[TBL] [Abstract][Full Text] [Related]
6. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
7. A practical comparison of group-sequential and adaptive designs.
Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
[TBL] [Abstract][Full Text] [Related]
8. Sample size re-estimation for survival data in clinical trials with an adaptive design.
Togo K; Iwasaki M
Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
[TBL] [Abstract][Full Text] [Related]
9. Stopping boundaries adjusted for sample size reestimation and negative stop.
Shun Z
J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
[TBL] [Abstract][Full Text] [Related]
10. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
Mütze T; Friede T
Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
[TBL] [Abstract][Full Text] [Related]
11. Self-designing trial combined with classical group sequential monitoring.
Yin G; Shen Y
J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
[TBL] [Abstract][Full Text] [Related]
12. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
13. Adaptive increase in sample size when interim results are promising: a practical guide with examples.
Mehta CR; Pocock SJ
Stat Med; 2011 Dec; 30(28):3267-84. PubMed ID: 22105690
[TBL] [Abstract][Full Text] [Related]
14. Increasing the sample size during clinical trials with t-distributed test statistics without inflating the type I error rate.
Timmesfeld N; Schäfer H; Müller HH
Stat Med; 2007 May; 26(12):2449-64. PubMed ID: 17080491
[TBL] [Abstract][Full Text] [Related]
15. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
16. Adaptive design and estimation in randomized clinical trials with correlated observations.
Yin G; Shen Y
Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
[TBL] [Abstract][Full Text] [Related]
17. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
[TBL] [Abstract][Full Text] [Related]
18. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
19. Modifications of sequential designs in bioequivalence trials.
Zheng C; Zhao L; Wang J
Pharm Stat; 2015; 14(3):180-8. PubMed ID: 25663282
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
Levin GP; Emerson SC; Emerson SS
Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
